高级检索
当前位置: 首页 > 详情页

Repeated Whole-Body Exposure to Low-Dose Radiation Combined With Topical Application of Basic Fibroblast Growth Factor and Zinc Accelerates Wound Healing in Diabetic Rats

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Jilin Univ, Hosp 1, Dept Intervent Therapy, Changchun, Jilin, Peoples R China [2]Jilin Univ, Dept Endocrinol & Metab, Hosp 1, Changchun 130021, Jilin, Peoples R China [3]Tongren Hosp, Dept Endocrinol, Shanghai, Peoples R China [4]Gen Hosp PLA Rocket Force, Lab Radiat Damage Res, Beijing, Peoples R China [5]Univ Louisville, Dept Radiat Oncol, Louisville, KY 40292 USA [6]Univ Louisville, Pediat Res Inst, Dept Pediat, Louisville, KY 40292 USA
出处:
ISSN:

关键词: diabetes mellitus skin wound healing combined treatment

摘要:
We reported the acceleration of skin wound healing in diabetic rats by repeated exposure to low-dose radiation (LDR). Here, we explored whether the wound healing could be further improved when LDR was combined with a topical application of basic fibroblast growth factor (bFGF) or zinc. Wounds were established on the backs of type 1 diabetic rats induced by a single injection of streptozotocin. Rats were treated daily with normal saline (Diabetes), LDR, bFGF, zinc, or combined 3 treatments for 5 consecutive days with a 2-day break between each consecutive 5-day treatment. Changes in wound size, histopathology, and microvessel density were assessed on days 5, 10, and 15, respectively, once treatment is started. All treatment regimens significantly accelerated skin wound healing, tissue remodeling, and new vessel formation compared to diabetes group. However, the combined LDR plus bFGF and zinc provided a better beneficial effect on wound healing than either one of these treatments alone. Further, we found that the effects of LDR and bFGF were similar, whereas zinc alone induced a weaker response. Our results suggest that whole-body LDR plus the topical application of bFGF and zinc can further accelerate wound healing in diabetic rats.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 4 区 医学
小类 | 4 区 药学 4 区 核医学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 药学 4 区 核医学
JCR分区:
出版当年[2016]版:
Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Q3 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Q3 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Jilin Univ, Hosp 1, Dept Intervent Therapy, Changchun, Jilin, Peoples R China
通讯作者:
通讯机构: [2]Jilin Univ, Dept Endocrinol & Metab, Hosp 1, Changchun 130021, Jilin, Peoples R China [*1]Department of Endocrinology and Metabolism, the First Hospital of Jilin University, Changchun 130021, Jilin, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:23549 今日访问量:2 总访问量:1284 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)